Integra LifeSciences Holdings Debt to Equity Ratio 2006-2019 | IART

Current and historical debt to equity ratio values for Integra LifeSciences Holdings (IART) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Integra LifeSciences Holdings debt/equity for the three months ending June 30, 2019 was 0.99.
Integra LifeSciences Holdings Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-06-30 $1.40B $1.42B 0.99
2019-03-31 $1.33B $1.40B 0.95
2018-12-31 $1.33B $1.38B 0.97
2018-09-30 $1.42B $1.37B 1.04
2018-06-30 $1.48B $1.34B 1.10
2018-03-31 $1.77B $1.00B 1.78
2017-12-31 $1.78B $0.96B 1.85
2017-09-30 $1.15B $0.91B 1.26
2017-06-30 $0.87B $0.90B 0.97
2017-03-31 $0.85B $0.85B 1.00
2016-12-31 $0.67B $0.84B 0.79
2016-09-30 $0.66B $0.82B 0.80
2016-06-30 $0.68B $0.80B 0.86
2016-03-31 $0.71B $0.78B 0.92
2015-12-31 $0.70B $0.75B 0.93
2015-09-30 $0.72B $0.73B 0.99
2015-06-30 $0.64B $0.71B 0.90
2015-03-31 $0.61B $0.69B 0.89
2014-12-31 $0.63B $0.70B 0.89
2014-09-30 $0.62B $0.69B 0.91
2014-06-30 $0.63B $0.69B 0.92
2014-03-31 $0.63B $0.68B 0.93
2013-12-31 $0.39B $0.67B 0.59
2013-09-30 $0.55B $0.50B 1.09
2013-06-30 $0.54B $0.52B 1.05
2013-03-31 $0.52B $0.51B 1.02
2012-12-31 $0.52B $0.52B 1.00
2012-09-30 $0.52B $0.53B 0.98
2012-06-30 $0.52B $0.51B 1.02
2012-03-31 $0.52B $0.51B 1.03
2011-12-31 $0.53B $0.49B 1.08
2011-09-30 $0.54B $0.50B 1.08
2011-06-30 $0.49B $0.52B 0.95
2011-03-31 $0.29B $0.53B 0.56
2010-12-31 $0.30B $0.50B 0.59
2010-09-30 $0.37B $0.47B 0.78
2010-06-30 $0.37B $0.46B 0.81
2010-03-31 $0.30B $0.46B 0.65
2009-12-31 $0.31B $0.45B 0.69
2009-09-30 $0.31B $0.43B 0.71
2009-06-30 $0.31B $0.40B 0.76
2009-03-31 $0.43B $0.37B 1.15
2008-12-31 $0.46B $0.37B 1.23
2008-09-30 $0.33B $0.32B 1.03
2008-06-30 $0.33B $0.32B 1.02
2008-03-31 $0.33B $0.29B 1.14
2007-12-31 $0.33B $0.26B 1.27
2007-09-30 $0.33B $0.25B 1.32
2007-06-30 $0.33B $0.22B 1.48
2007-03-31 $0.00B $0.31B 0.00
2006-12-31 $0.00B $0.30B 0.00
2006-09-30 $0.01B $0.31B 0.02
2006-06-30 $0.12B $0.31B 0.38
2006-03-31 $0.12B $0.31B 0.38
2005-12-31 $0.12B $0.29B 0.41
2005-09-30 $0.12B $0.31B 0.39
2005-06-30 $0.12B $0.30B 0.40
2005-03-31 $0.12B $0.31B 0.38
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.300B $1.472B
Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic surgery, neurosurgery, reconstructive and general surgery. Integra's orthopedic products include devices and implants for foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. Surgeons don't have a minute to waste. They navigate a world of uncertainty while making thousands of decisions every day. These decisions directly affect patients - and surgeons.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $112.770B 24.03
Intuitive Surgical (ISRG) United States $61.015B 48.08
Edwards Lifesciences (EW) United States $47.375B 46.11
IDEXX Laboratories (IDXX) United States $24.289B 60.94
Fresenius Medical Care AG KGaA (FMS) Germany $20.671B 13.87
Olympus (OCPNY) Japan $18.355B 137.85
Teleflex (TFX) United States $15.166B 32.19
SONOVA HOLDING (SONVY) Switzerland $14.881B 0.00
DexCom (DXCM) United States $14.286B 211.72
Sysmex ADR (SSMXY) Japan $13.491B 36.31
Hologic (HOLX) United States $13.192B 20.82
STERIS (STE) Ireland $12.123B 27.96
Varian Medical Systems (VAR) United States $10.392B 24.86
ABIOMED (ABMD) United States $8.010B 45.85
Masimo (MASI) United States $7.894B 47.90
SARTORIUS AG (SARTF) Germany $5.614B 49.88
Penumbra (PEN) United States $5.111B 183.63
Globus Medical (GMED) United States $5.055B 32.08
Elekta AB (EKTAY) Sweden $4.879B 37.56
Tandem Diabetes Care (TNDM) United States $3.697B 0.00
LivaNova (LIVN) United Kingdom $3.581B 27.30
Cantel Medical (CMD) United States $3.015B 30.45
Wright Medical Group (WMGI) Netherlands $2.650B 232.44
Nevro (NVRO) United States $2.638B 0.00
Nihon Kohden (NHNKY) Japan $2.589B 26.05
Integer Holdings (ITGR) United States $2.465B 17.44
Glaukos (GKOS) United States $2.365B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.882B 34.90
OPKO Health (OPK) United States $1.336B 0.00
Veracyte (VCYT) United States $1.227B 0.00
Natus Medical (NTUS) United States $1.102B 25.67
Inogen (INGN) United States $1.083B 26.55
Silk Road Medical (SILK) United States $1.051B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.997B 31.30
Accelerate Diagnostics (AXDX) United States $0.956B 0.00
Mesa Laboratories (MLAB) United States $0.948B 39.42
Tactile Systems Technology (TCMD) United States $0.915B 113.09
Luminex (LMNX) United States $0.909B 0.00
CryoLife (CRY) United States $0.903B 85.96
Corindus Vascular Robotics (CVRS) United States $0.893B 0.00
Pacific Biosciences Of California (PACB) United States $0.834B 0.00
AngioDynamics (ANGO) United States $0.565B 20.28
OrthoPediatrics (KIDS) United States $0.553B 0.00
Intersect ENT (XENT) United States $0.526B 0.00
Quotient (QTNT) Switzerland $0.526B 0.00
AxoGen (AXGN) United States $0.492B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.416B 15.97
Si-Bone (SIBN) United States $0.388B 0.00
Alphatec Holdings (ATEC) United States $0.328B 0.00
GenMark Diagnostics (GNMK) United States $0.321B 0.00
Sientra (SIEN) United States $0.320B 0.00
Fluidigm (FLDM) United States $0.299B 0.00
Semler Scientific (SMLR) United States $0.284B 47.80
IRadimed (IRMD) United States $0.261B 43.32
ViewRay (VRAY) United States $0.260B 0.00
Stereotaxis (STXS) United States $0.234B 0.00
Accuray (ARAY) United States $0.227B 0.00
CRH Medical (CRHM) Canada $0.217B 75.25
SeaSpine Holdings (SPNE) United States $0.210B 0.00
RTI Surgical (RTIX) United States $0.201B 30.22
Neuronetics (STIM) United States $0.167B 0.00
ConforMIS (CFMS) United States $0.159B 0.00
EDAP TMS S.A (EDAP) France $0.133B 65.57
T2 Biosystems (TTOO) United States $0.116B 0.00
Second Sight Medical Products (EYES) United States $0.103B 0.00
TransEnterix (TRXC) United States $0.095B 0.00
Sensus Healthcare (SRTS) United States $0.092B 0.00
Spectral Diagnostics (EDTXF) Canada $0.072B 0.00
Apollo Endosurgery (APEN) United States $0.065B 0.00
Electromed (ELMD) United States $0.055B 28.09
Vermillion (VRML) United States $0.045B 0.00
Ekso Bionics Holdings (EKSO) United States $0.043B 0.00
Bioanalytical Systems (BASI) United States $0.043B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.042B 0.00
Helius Medical Technologies (HSDT) United States $0.042B 0.00
Xtant Medical Holdings (XTNT) United States $0.032B 0.00
Neovasc (NVCN) Canada $0.027B 0.00
Nuvectra (NVTR) United States $0.027B 0.00
ReWalk Robotics (RWLK) Israel $0.021B 0.00
Ra Medical Systems (RMED) United States $0.019B 0.00
Restoration Robotics (HAIR) United States $0.017B 0.00
American Shared Hospital Services (AMS) United States $0.014B 20.33
Cesca Therapeutics (KOOL) United States $0.013B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
Lianluo Smart (LLIT) China $0.013B 0.00
DarioHealth (DRIO) Israel $0.011B 0.00
OBALON THERPTCS (OBLN) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.008B 0.00
Dynatronics (DYNT) United States $0.008B 0.00
Viveve Medical (VIVE) United States $0.007B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Avinger (AVGR) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Allied Healthcare Products (AHPI) United States $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.004B 0.00
InspireMD (NSPR) Israel $0.002B 0.00